Early Relief Of Pain Symptoms Predicts The Improvement Of Anxiety In Generalized Anxiety Disorder Patients With Painful Physical Symptoms Receiving Venlafaxine Treatment

Xiandi Pan,Yiyun Cai,Xiao Huang,Xiaoduo Fan,Yanli Luo
2016-01-01
Abstract:Objective: This study aimed to investigate the clinical characteristics of the generalized anxiety disorder (GAD) patients with painful physical symptoms (PPS) and assess the efficacy of venlafaxine in the treatment of GAD patients with PPS. Methods: 180 GAD patients with PPS were enrolled and received venlafaxine treatment for 8 weeks. Hamilton Anxiety Scale (HAMA) and The Medical Outcome Study Pain Measures (MOSPM) were used to assess the anti-anxiety and analgesic effects of venlafaxine. Results: The anxiety was associated with pain severity in GAD patients; HAMA total score and subscale score as well as MOSPM total score and subscale score decreased significantly after 8-week treatment; early improvement of pain symptoms was a predictor of anxiety alleviation. Conclusion: Venlafaxine is effective to relieve anxiety and pain symptoms in GAD patients with PPS, and early improvement of pain symptoms is predictive of anxiety alleviation in these patients.
What problem does this paper attempt to address?